GR3024453T3 - 5-(piperazinylalkyl)-1,5-benzothiazepinones useful as calcium antagonists. - Google Patents

5-(piperazinylalkyl)-1,5-benzothiazepinones useful as calcium antagonists.

Info

Publication number
GR3024453T3
GR3024453T3 GR970401977T GR970401977T GR3024453T3 GR 3024453 T3 GR3024453 T3 GR 3024453T3 GR 970401977 T GR970401977 T GR 970401977T GR 970401977 T GR970401977 T GR 970401977T GR 3024453 T3 GR3024453 T3 GR 3024453T3
Authority
GR
Greece
Prior art keywords
optionally substituted
useful
hydrogen
benzothiazepinones
piperazinylalkyl
Prior art date
Application number
GR970401977T
Other languages
English (en)
Inventor
Teruo Yamamori
Horoshi Harada
Katsunori Sakai
Kazumi Iwaki
Kazuki Matsunaga
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of GR3024453T3 publication Critical patent/GR3024453T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GR970401977T 1991-10-21 1997-08-14 5-(piperazinylalkyl)-1,5-benzothiazepinones useful as calcium antagonists. GR3024453T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP30234891 1991-10-21
EP92309474A EP0541263B1 (en) 1991-10-21 1992-10-16 5-piperazinylalkyl-1,5-benzothiazepinones useful as calcium antagonists

Publications (1)

Publication Number Publication Date
GR3024453T3 true GR3024453T3 (en) 1997-11-28

Family

ID=17907840

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970401977T GR3024453T3 (en) 1991-10-21 1997-08-14 5-(piperazinylalkyl)-1,5-benzothiazepinones useful as calcium antagonists.

Country Status (12)

Country Link
US (2) US5378698A (el)
EP (2) EP0615971B1 (el)
JP (1) JP2818082B2 (el)
KR (1) KR100214902B1 (el)
CN (1) CN1034075C (el)
AT (2) ATE116974T1 (el)
CA (1) CA2080671A1 (el)
DE (2) DE69201184T2 (el)
DK (2) DK0541263T3 (el)
ES (2) ES2106439T3 (el)
GR (1) GR3024453T3 (el)
TW (1) TW221429B (el)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG50796A1 (en) * 1996-02-23 1998-07-20 Tanabe Seiyaku Co Process for preparing 1,5-benzothiazepine derivative
IL123352A0 (en) 1997-02-27 1998-09-24 Tanabe Seiyaku Co Process for preparing an optically active trans-3-substituted glycidic acid ester
UA67760C2 (uk) * 1997-12-11 2004-07-15 Міннесота Майнінг Енд Мануфакчурінг Компані Імідазонафтиридин та тетрагідроімідазонафтиридин, фармацевтична композиція, спосіб індукування біосинтезу цитокінів та спосіб лікування вірусної інфекції, проміжні сполуки
US6897305B2 (en) * 1998-06-08 2005-05-24 Theravance, Inc. Calcium channel drugs and uses
US7101909B2 (en) * 1998-10-12 2006-09-05 Theravance, Inc. Calcium channel drugs and uses
CN1872846B (zh) * 1999-07-09 2010-06-16 宇部兴产株式会社 二苯并硫氮*衍生物的制备方法
WO2002000850A1 (fr) * 2000-06-28 2002-01-03 Takeda Chemical Industries, Ltd. Procede servant a preparer des cellules du muscle cardiaque et procede servant a rechercher des agents therapeutiques de maladies cardiaques
US7550459B2 (en) 2001-12-28 2009-06-23 Acadia Pharmaceuticals, Inc. Tetrahydroquinoline analogues as muscarinic agonists
CN100402032C (zh) 2001-12-28 2008-07-16 阿卡蒂亚药品公司 用作毒蕈碱激动剂的四氢喹啉类似物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3075967A (en) * 1961-06-12 1963-01-29 Olin Mathieson Benzothiazines
US4567175A (en) * 1983-06-03 1986-01-28 Tanabe Seiyaku Co., Ltd. 8-Chloro-1,5-benzothiazepine derivatives
US4594342A (en) * 1984-04-10 1986-06-10 Tanabe Seiyaku Co., Ltd. 1,5-benzothiazepine derivative
US4584131A (en) * 1985-06-20 1986-04-22 E. R. Squibb & Sons, Inc. Benzothiazepine derivatives
US5028610A (en) * 1987-03-18 1991-07-02 Sankyo Company Limited N-benzhydryl-substituted heterocyclic derivatives, their preparation and their use
US4879289A (en) * 1988-05-24 1989-11-07 Marion Laboratories, Inc. Method of ameliorating epileptic seizures
US4963545A (en) * 1988-05-24 1990-10-16 Marion Laboratories, Inc. Benzothiazepine anti-seizure method
FR2645744B1 (fr) * 1989-04-13 1994-01-21 Roussel Uclaf Derives de la benzothiazepine, leur procede de preparation et les intermediaires ainsi obtenus, leur application comme medicaments et les compositions les renfermant
CA2030159A1 (en) * 1989-11-22 1991-05-23 Nahed K. Ahmed Anti-cancer drug potentiators
US5001236A (en) * 1989-11-22 1991-03-19 Marion Laboratories, Inc. Benzothiazepines

Also Published As

Publication number Publication date
EP0541263B1 (en) 1995-01-11
EP0615971A1 (en) 1994-09-21
ATE156821T1 (de) 1997-08-15
JPH05201865A (ja) 1993-08-10
CN1034075C (zh) 1997-02-19
DK0615971T3 (da) 1997-10-06
CA2080671A1 (en) 1993-04-22
EP0615971B1 (en) 1997-08-13
DE69221634T2 (de) 1998-01-15
US5378698A (en) 1995-01-03
ES2106439T3 (es) 1997-11-01
EP0541263A1 (en) 1993-05-12
DE69201184T2 (de) 1995-06-08
KR100214902B1 (ko) 1999-08-02
DE69221634D1 (de) 1997-09-18
DE69201184D1 (de) 1995-02-23
ATE116974T1 (de) 1995-01-15
ES2069967T3 (es) 1995-05-16
CN1073168A (zh) 1993-06-16
TW221429B (el) 1994-03-01
US5462936A (en) 1995-10-31
JP2818082B2 (ja) 1998-10-30
KR930007943A (ko) 1993-05-20
DK0541263T3 (da) 1995-04-18

Similar Documents

Publication Publication Date Title
DK0528337T3 (da) Thiazolylbenzofuranderivater, fremgangsmåde til fremstilling deraf og farmaceutiske præparater, der indeholder disse forbin
EP0976748A4 (en) PYRROLIDINE DERIVATIVES HAVING PHOSPHOLIPASE A2 INHIBITING ACTIVITY
HK1010881A1 (en) Derivatives of azetidine and pyrrolidine
AU8405891A (en) Indole derivative and medicine
GR3024453T3 (en) 5-(piperazinylalkyl)-1,5-benzothiazepinones useful as calcium antagonists.
PH24309A (en) Cycloalkylamides of(8beta)-1-alkyl-6-(substituted)-ergolines and pharmaceutical formulations thereof
IL85768A (en) Benzoxazine derivatives, their preparation and pharmaceutical compositions containing them
NZ227682A (en) Thioformamide derivatives, preparation thereof and pharmaceutical compositions
DE3674546D1 (de) Amidderivate.
ZA892312B (en) 7-(imidazol-1-yl)-1,4-dihydro-4-oxo-6,8-difluoro-1-cyclo-propylquinoline-3-carboxylic acid derivatives their preparation and their application as drugs